VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party.

Pharmaceutical

Velocity Pharmaceutical Development

Velocity Pharmaceutical Development's headquarters in South San Francisco, CA, United States

David Collier

Sonia Kamal

Anie Roche

Andrew Perlman

Edward Schnipper

James Larrick

Samuel R. Saks

Karen D. Talmadge

Wayne Roe

James F. Watson

This department oversees strategic direction and decision-making for the organization.

Executive Leadership

The Leadership Team at Velocity Pharmaceutical Development is responsible for defining the company’s strategic direction, overseeing the management of project-focused companies, and driving decision-making related to drug candidate acquisitions. Composed of seasoned executives, the team collaborates to ensure effective risk management, operational excellence, and alignment with VPD's mission to innovate and advance pharmaceutical development.

Leadership Team

The Medical and Legal Team at Velocity Pharmaceutical Development is responsible for ensuring the scientific integrity and regulatory compliance of drug candidates within the portfolio. This team collaborates closely to evaluate clinical data, navigate legal frameworks, and manage intellectual property issues, all while ensuring adherence to industry standards and ethical practices. Their combined expertise safeguards the company's investments and supports successful project outcomes.

Velocity Pharmaceutical Development

Org chart

Board & advisors

Teams

Executive Leadership

Leadership Team

Medical and Legal Team

Offices

Velocity Pharmaceutical Development

Org chart

Board & advisors

Teams

Executive Leadership

Leadership Team

Medical and Legal Team

Offices

Related companies